June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Integrative ‘omics analyses to investigate trabecular meshwork changes in glaucoma
Author Affiliations & Notes
  • Angela Banks
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Vijaykrishna Raghunathan
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Rachida Bouhenni
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Angela Chui
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Thomas Vollmer
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Parvaneh Katoli
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Qin Zhang
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Lin Fan
    Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Yanqun Wang
    Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Ganesh Prasanna
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Chia-Ling Huang
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Christopher W. Wilson
    Ophthalmology, Novartis Institutes for BioMedical Research Inc, Cambridge, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Angela Banks Novartis Institutes for Biomedical Research, Code E (Employment); Vijaykrishna Raghunathan Novartis Institutes for Biomedical Research, Code E (Employment); Rachida Bouhenni Novartis Institutes for Biomedical Research, Code E (Employment); Angela Chui Novartis Institutes for Biomedical Research, Code E (Employment); Thomas Vollmer Novartis Institutes for Biomedical Research, Code E (Employment); Parvaneh Katoli Novartis Institutes for Biomedical Research, Code E (Employment); Qin Zhang Novartis Institutes for Biomedical Research, Code E (Employment); Lin Fan Novartis Institutes for Biomedical Research, Code E (Employment); Yanqun Wang Novartis Institutes for Biomedical Research, Code E (Employment); Ganesh Prasanna Novartis Institutes for Biomedical Research, Code E (Employment); Chia-Ling Huang Novartis Institutes for Biomedical Research, Code E (Employment); Christopher Wilson Novartis Institutes for Biomedical Research, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1850. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Angela Banks, Vijaykrishna Raghunathan, Rachida Bouhenni, Angela Chui, Thomas Vollmer, Parvaneh Katoli, Qin Zhang, Lin Fan, Yanqun Wang, Ganesh Prasanna, Chia-Ling Huang, Christopher W. Wilson; Integrative ‘omics analyses to investigate trabecular meshwork changes in glaucoma. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1850.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The trabecular meshwork (TM) is the primary site of resistance to aqueous humor outflow, yet its molecular changes associated with dysregulated outflow in glaucoma are unknown. To investigate and characterize TM subtypes that may be implicated in glaucoma, we applied single nuclei RNA-sequencing on non-glaucomatous and glaucomatous human donor limbal ring tissue.

Methods : Limbal ring tissues were collected and flash-frozen within 6 hours post-mortem from 6 glaucomatous and 5 non-glaucomatous human donors. Samples were thawed and lysed to isolate nuclei, then barcoded using 10X Genomics Single Cell 3’ gene expression kit (v2 chemistry). Libraries were sequenced on Illumina NovaSeq 6000. Sequencing data were demultiplexed and aligned to the GRCh38 genome using 10X’s Cell Ranger software.
Single nuclei RNA-seq quality control, normalization, clustering, and differential expression analysis were run using the Seurat R package. Pathway activity scores were calculated using the AUCell R package. Deconvolution of an internal limbal ring glaucoma bulk RNA-seq study was run using the MuSiC R package. Bulk RNA-seq differential expression analysis was run using edgeR and limma R packages.

Results : By clustering our single nuclei data by pathway activity scores, we identified 6 putative TM subtypes, including a subtype (TM2) which expands in proportion with glaucoma. Genes upregulated in this “glaucoma-associated” TM subtype were related to extracellular matrix (log2FC ≥ 0.25; FDR ≤ 0.05). These genes showed stable expression in this TM population across most donors. Using our single nuclei data, we deconvolved a larger, independent glaucoma limbal ring bulk RNA-seq study (10 glaucoma, 7 non-glaucoma donors) and observed a reproducible expansion of this TM2 subtype in glaucoma.

Conclusions : Our data demonstrates that by applying novel clustering approaches using pathway activity scores, we can identify and characterize a TM subtype which may be implicated in glaucoma. Integrative snRNA-seq and bulk RNA-seq analysis reinforces our findings and facilitates target identification efforts. Further studies are needed to determine whether this identified trabecular meshwork subtype is causative or correlated to glaucoma and enable identification of new therapeutic pathways.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×